Risk stratification using gated stress myocardial perfusion imaging: comparison between patients with and without sexual dysfunction

Basit Öğe Kaydı
dc.authoridAkbas, Alpaslan/0000-0003-1470-5952
dc.contributor.authorTan, Yusuf Ziya
dc.contributor.authorOzdemir, Semra
dc.contributor.authorBekler, Adem
dc.contributor.authorAkbas, Alpaslan
dc.contributor.authorGencer, Meryem
dc.contributor.authorCelik, Fatmanur
dc.date.accessioned2025-01-27T20:22:54Z
dc.date.available2025-01-27T20:22:54Z
dc.date.issued2016
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractSexuality is an indispensable part of life. When a problem is encountered related to this topic, the quality of life is negatively affected. Therefore, every problem related to sexuality is extremely private and important to an individual. This study aims to investigate the use of myocardial perfusion scintigraphy (MPS) for advanced assessment of patients with known or suspected coronary artery disease, cardiovascular disease, and in the intermediate risk group for SD. The study included 250 patients (150 male, 100 female, mean age 54 +/- 12.10) sent by the Cardiology Clinic to the Nuclear Medicine Clinic for MPS due to suspected cardiovascular disease (CVD). The questionnaire study was applied by two methods as face-to-face interviews or online. Data on sociodemographic characteristics and cardiovascular diseases together with risk factors for sexual activity were collected using a general information form. Patients were divided into three categories of risk depending on major risk factors for cardiovascular diseases: low, intermediate, and high risk. On comparing the risk scores between the groups, it was seen that there was a statistically clear reduction in the intermediate risk group of patients with SD according to MPS scoring. MPS is a cost-effective, reliable, and accurate non-invasive diagnostic method necessary for routine use to assess cardiovascular disease and in the intermediate risk group for SD.
dc.identifier.doi10.1136/jim-d-15-00105
dc.identifier.endpage44
dc.identifier.issn1081-5589
dc.identifier.issn1708-8267
dc.identifier.issue1
dc.identifier.pmid26755812
dc.identifier.scopus2-s2.0-84979985605
dc.identifier.scopusqualityQ2
dc.identifier.startpage39
dc.identifier.urihttps://doi.org/10.1136/jim-d-15-00105
dc.identifier.urihttps://hdl.handle.net/20.500.12428/22066
dc.identifier.volume64
dc.identifier.wosWOS:000368699600007
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBmj Publishing Group
dc.relation.ispartofJournal of Investigative Medicine
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectAnt-CCP
dc.subjectAutoantibodies
dc.subjectRheumatoid Arthritis
dc.subjectFibromyalgis
dc.subjectPain Syndromes
dc.titleRisk stratification using gated stress myocardial perfusion imaging: comparison between patients with and without sexual dysfunction
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu